Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.26
Delayed Data
As of Jun 01
 +0.015 / +0.35%
Today’s Change
1.89
Today|||52-Week Range
6.37
-16.31%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Progenics Pharmaceuticals Inc have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a +52.58% increase from the last price of 4.26.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Progenics Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$8.2M
Reporting Date
Aug 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.63%
 
 
 
 
 
 
Growthannually -12.50%
 
 
 
 
 
 

Sales

Growthquarterly 31.24%
 
 
 
 
 
 
Growthannually 5.18%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.